$CLOV - $1.875B projected revenue, $2B market cap. make it make sense to me. what am i missing ?

***Issues full year 2025 guidance:***

* *Average Medicare Advantage membership of 103,000 - 107,000, representing30%growth year-over-year at the midpoint*
* ***Insurance revenue between$1.800 billion and$1.875 billion, representing37%growth year-over-year at the midpoint***
* *Adjusted EBITDA profitability between$45 millionand$70 million*
* *Adjusted Net income between$45 millionand$70 million*

Source of summary -

[https://www.stocktitan.net/news/CLOV/clover-health-reports-fourth-quarter-and-full-year-2024-results-xqlhts1l2ne3.html](https://www.stocktitan.net/news/CLOV/clover-health-reports-fourth-quarter-and-full-year-2024-results-xqlhts1l2ne3.html)

Clover Health's 2024 results reveal a remarkable financial turnaround, with the company achieving **$70 million in Adjusted EBITDA** for 2024 compared to a **$42 million** loss in 2023 – a **$112 million** year-over-year improvement. This shift to profitability represents a critical inflection point for a company that has historically struggled with high medical costs.

The most telling metric is Clover's Insurance Benefits Expense Ratio (BER) improvement to **81.2%** for full-year 2024, down from **86.5%** in 2023. This 530 basis point improvement directly translates to approximately **$69 million** in additional margin on their **$1.3 billion** insurance revenue base. In the Medicare Advantage industry, where typical margins are thin, this level of medical cost improvement is exceptional.

Clover's 2025 guidance signals confidence in their business model, projecting **30%** membership growth and **37%** revenue growth while maintaining profitability. The upcoming 4.0 Star Rating for payment year 2026 will provide a substantial revenue boost through enhanced CMS reimbursements – typically 5% higher than non-bonus plans.

The company's technology-first approach with the Clover Assistant platform appears to be delivering on its promise of better care management and cost control. Their positive cash flow from operations in 2024 marks another critical milestone, reducing concerns about future capital needs.

While balancing rapid growth with profitability remains challenging in healthcare insurance, Clover's improved cost structure and technology platform position them to potentially achieve both objectives – something many Medicare Advantage startups have failed to accomplish.